Market Introduction
Master patient index (MPI) is an essential as well as critical part of every hospital or a healthcare facility center. To maintain the huge database of patients’ MPI software or systems are used. MPI software or system is a primary feature build in the electronic health record (HER) to maintain a universal identity of patients at the organizational level. MPI helps in connecting patient records from several databases and reduces data duplication of patients. MPI also helps avoiding inaccuracy of data resulting in improper treatments.
Thus, the adoption of cloud-based technologies is expected to create a significant demand for master patient index software in the coming years, which is further anticipated to drive the master patient index software market.
The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. It suffers from severe inequalities. State-run hospitals and clinics are already overstressed by treating vector?borne diseases and community?acquired infections, and high rates of non?communicable diseases (NCDs). Also, the prevention and treatment of NCDs have been critically affected since the onset of the COVID-19 in the region, as per the Pan American Health Organization (PAHO). Before COVID-19, approximately 81% of all deaths in the region were due to NCDs. An estimated 62 million people live with diabetes, and 1.2 million live with cancer in South and Central America. Moreover, in South and Central America, the Gross Domestic Product (GDP) and central government healthcare expenditure are significantly lower than in developed countries. In 2018, as per the United Nations Economic Commission for Latin America (CEPAL), 16 South American countries invested less than 4% of their GDP in healthcare. The consequences of a lack of investment in public healthcare systems are reflecting during the pandemic. The COVID?19 pandemic is exacerbating these inequalities by threatening the infrastructure and capacity of state?owned healthcare systems. Thus, the factors mentioned above are negatively impacting the growth of the market in the region.
Market Overview and Dynamics
The Master patient index software market in South and Central America is expected to grow from US$ 44.9 million in 2021 to US$ 83.1 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. Continuously rising need of better healthcare services, as a basic requirement, is encouraging advancements in the healthcare sector in developing countries in South and Central America. Healthcare IT solutions benefit through reduced inefficiencies, accurate diagnosis and treatment, and lowered healthcare costs, among others. The solutions also help healthcare service providers in offering customized medication, quick diagnosis of new aliments, and better access to healthcare services, thereby improving the quality of life of people. Thus, the focus in having unified medical record systems in developing countries is serving significant opportunities for the master patient index software providers.
Key Market Segments
In terms of type, the software segment accounted for the largest share of the South and Central America master patient index software market in 2020. In terms of deployment, the cloud-based segment held a larger market share of the master patient index software market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the master patient index software market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are McKESSON CORPORATION, Oracle Corporation, Wipro Limited, Allscripts Healthcare Solutions, Inc., MEDITECH, and Intersystems Corporation.
Reasons to buy report
SOUTH AND CENTRAL AMERICA MASTER PATIENT INDEX SOFTWARE MARKET SEGMENTATION
By Type
By Deployment
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 44.9 Million |
| Market Size by 2028 | US$ 83.1 Million |
| CAGR (2021 - 2028) | 9.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Master Patient Index Software Market is valued at US$ 44.9 Million in 2021, it is projected to reach US$ 83.1 Million by 2028.
As per our report South and Central America Master Patient Index Software Market, the market size is valued at US$ 44.9 Million in 2021, projecting it to reach US$ 83.1 Million by 2028. This translates to a CAGR of approximately 9.2% during the forecast period.
The South and Central America Master Patient Index Software Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Master Patient Index Software Market report:
The South and Central America Master Patient Index Software Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Master Patient Index Software Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Master Patient Index Software Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)